By proceeding, you agree to our Terms of Use and Privacy Policy.
Global drug development professional with a robust history of success as a key contributor in the design and execution of clinical drug programs for regulatory approvals and labeling updates across multiple therapeutic areas, including rare diseases.
Talks About #drugdevelopment #medical
Preferred Locations #NorthAmerica
Welcome to the 6th Obesity & NASH Drug Development Summit There has been a rise and fall of investment in NASH in the wake of highly demanding biopsy endpoints and late-stage clinical setbacks.
